Targeted Cerebral Oxygenation Using Dedicated Treatment Versus Usual Care in Extremely Preterm Infants: Protocol for a Multicentre International Phase II Randomised Controlled Trial
Journal of Paediatrics and Child Health · 2025
DOI: 10.1111/jpc.70066 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Paediatrics and Child Health, 2025. Verfasst von Pranav R Jani und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, Westmead Hospital, Westmead, Australia. Hauptthemen laut MEDLINE: Brain, Hypoxia, Brain, Infant, Extremely Premature, Oxygen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cerebral Palsy Alliance Research Foundation.
Themen: Neonatologie
Abstract (Originalsprache)
Background
Near infrared spectroscopy (NIRS) allows continuous monitoring of cerebral oxygenation and therefore has the potential to be neuroprotective. Recurrent episodes of cerebral hypo‐and/or hyperoxia may result in brain injury. The Safe‐BoosC‐II study reported stable cerebral oxygenation in extremely preterm infants by combining a dedicated treatment guideline with NIRS monitoring using several devices and adult sensors. The ability to maintain stable cerebral oxygenation with a dedicated treatment algorithm using one type of NIRS device with neonatal sensors has not been previously investigated.
Methods
In this multicentre, 2‐arm, parallel, single‐blinded, phase II RCT, stratified by gestation and hospital site, 100 participants born < 29 weeks' gestation (inborn and outborns, singleton and twins) will be randomised to targeted cerebral oxygenation using dedicated treatment or usual care with blinded cerebral NIRS monitoring for the first 5 days of life. We will exclude infants > 6 h of age, those with congenital anomaly requiring major surgery or a genetic disorder, and triples or higher multiple births. The primary outcome is the burden of cerebral hypoxia and hyperoxia for the first 5 days after birth expressed as percent hours.
Discussion
The findings of this trial will provide essential information on (i) validating results from the Safe‐BoosC‐II study, considering the differences in the study methodology between the two trials (ii) strengthening support for routine use of cerebral NIRS monitoring in this population and (iii) informing the design of future RCTs on the effects of targeted cerebral oxygenation on neurodevelopment in early childhood as the primary outcome. Trial Registration Australian New Zealand Clinical Trials Registry registration number ACTRN12621000778886
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neonatology, Westmead Hospital, Westmead, Australia.
- Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
- Department of Neonatology, Nepean Hospital, Nepean Blue Mountains Local Health District, Kingswood, Australia.
- Sydney Medical School Nepean, The University of Sydney, Sydney, New South Wales, Australia.
- Neonatal Intensive Care Unit, Wellington Regional Hospital, Wellington, New Zealand.
- Department of Paediatrics and Child Health, University of Otago, Wellington, New Zealand.
ORCID-Profile: Pranav R Jani, Traci-Anne Goyen, James Elhindi
Förderung
- Cerebral Palsy Alliance Research Foundation
Zitieren
APA
Jani, P. R., Goyen, T. A., Virupakshappa, K. K. B., Maheshwari, R., Shah, D., Saito-Benz, M., Schindler, T., Moore, J., Elhindi, J., Popat, H., & NIRTURE Trial Group (2025). Targeted Cerebral Oxygenation Using Dedicated Treatment Versus Usual Care in Extremely Preterm Infants: Protocol for a Multicentre International Phase II Randomised Controlled Trial. Journal of Paediatrics and Child Health. https://doi.org/10.1111/jpc.70066
Vancouver
Jani PR, Goyen TA, Virupakshappa KKB, Maheshwari R, Shah D, Saito-Benz M, et al. Targeted Cerebral Oxygenation Using Dedicated Treatment Versus Usual Care in Extremely Preterm Infants: Protocol for a Multicentre International Phase II Randomised Controlled Trial. Journal of Paediatrics and Child Health. 2025. doi:10.1111/jpc.70066
BibTeX
@article{Jani2025,
author = {Jani, Pranav R and Goyen, Traci-Anne and Virupakshappa, Kiran Kumar Balegar and Maheshwari, Rajesh and Shah, Dharmesh and Saito-Benz, Maria and Schindler, Tim and Moore, James and Elhindi, James and Popat, Himanshu and NIRTURE Trial Group, NIRTURE Trial Group},
title = {Targeted Cerebral Oxygenation Using Dedicated Treatment Versus Usual Care in Extremely Preterm Infants: Protocol for a Multicentre International Phase II Randomised Controlled Trial},
journal = {Journal of Paediatrics and Child Health},
year = {2025},
doi = {10.1111/jpc.70066}
}
EUVIMED